MX367362B - Nuevas formas solidas de desvenlafaxina. - Google Patents

Nuevas formas solidas de desvenlafaxina.

Info

Publication number
MX367362B
MX367362B MX2016008646A MX2016008646A MX367362B MX 367362 B MX367362 B MX 367362B MX 2016008646 A MX2016008646 A MX 2016008646A MX 2016008646 A MX2016008646 A MX 2016008646A MX 367362 B MX367362 B MX 367362B
Authority
MX
Mexico
Prior art keywords
desvenlafaxine
solid forms
desmethylvenlafaxine
menopause
polymorphs
Prior art date
Application number
MX2016008646A
Other languages
English (en)
Other versions
MX2016008646A (es
Inventor
Höpfl Herbert
Pablo Senosiain Pelaéz Juan
Guillermo Domínguez Chávez Jorge
Mondragón Vásquez Karina
Morales Rojas Hugo
Herrera Ruiz Dea
Reyes Martínez Reyna
HERNÁNDEZ ILLESCAS Javier
Original Assignee
Alparis Sa De Cv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alparis Sa De Cv filed Critical Alparis Sa De Cv
Priority to MX2016008646A priority Critical patent/MX367362B/es
Priority to PE2017001162A priority patent/PE20180025A1/es
Priority to CONC2017/0006492A priority patent/CO2017006492A1/es
Priority to CA2972156A priority patent/CA2972156C/en
Priority to ES201730859A priority patent/ES2648369B2/es
Priority to US15/636,818 priority patent/US10207982B2/en
Priority to SV2017005474A priority patent/SV2017005474A/es
Publication of MX2016008646A publication Critical patent/MX2016008646A/es
Publication of MX367362B publication Critical patent/MX367362B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/64—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D9/00—Crystallisation
    • B01D9/0018—Evaporation of components of the mixture to be separated
    • B01D9/0022—Evaporation of components of the mixture to be separated by reducing pressure
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L9/00—Supporting devices; Holding devices
    • B01L9/02—Laboratory benches or tables; Fittings therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/10—Separation; Purification; Stabilisation; Use of additives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/01—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups
    • C07C65/03—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups monocyclic and having all hydroxy or O-metal groups bound to the ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/01—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups
    • C07C65/03—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups monocyclic and having all hydroxy or O-metal groups bound to the ring
    • C07C65/05—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups monocyclic and having all hydroxy or O-metal groups bound to the ring o-Hydroxy carboxylic acids
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D9/00—Crystallisation
    • B01D9/0018—Evaporation of components of the mixture to be separated
    • B01D9/0031—Evaporation of components of the mixture to be separated by heating
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D9/00—Crystallisation
    • B01D9/004—Fractional crystallisation; Fractionating or rectifying columns
    • B01D9/0045—Washing of crystals, e.g. in wash columns
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D9/00—Crystallisation
    • B01D9/02—Crystallisation from solutions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Clinical Laboratory Science (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La presente invención se refiere a nuevas formas sólidas amorfas y cristalinas de desvenlafaxina, también llamado O-desmetilvenlafaxina o desmetilvenlafaxina, y a sus sales, solvatos, hidratos y polimorfos de las mismas, así como a su uso en la preparación de una composición farmacéutica útil para el tratamiento de la depresión y/o inhibidor selectivo de la reabsorción de serotonina y la norepinefrina así como a los trastornos vasomotores asociados a la menopausia.
MX2016008646A 2016-06-29 2016-06-29 Nuevas formas solidas de desvenlafaxina. MX367362B (es)

Priority Applications (7)

Application Number Priority Date Filing Date Title
MX2016008646A MX367362B (es) 2016-06-29 2016-06-29 Nuevas formas solidas de desvenlafaxina.
PE2017001162A PE20180025A1 (es) 2016-06-29 2017-06-27 Nuevas formas solidas de desvenlafaxina
CONC2017/0006492A CO2017006492A1 (es) 2016-06-29 2017-06-27 Nuevas formas sólidas de desvenlafaxina
CA2972156A CA2972156C (en) 2016-06-29 2017-06-28 Solid forms of desvenlafaxine
ES201730859A ES2648369B2 (es) 2016-06-29 2017-06-28 Nuevas formas sólidas de desvenlafaxina
US15/636,818 US10207982B2 (en) 2016-06-29 2017-06-29 Solid forms of desvenlafaxine
SV2017005474A SV2017005474A (es) 2016-06-29 2017-06-29 Nuevas formas sólidas de desvenlafaxina

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2016008646A MX367362B (es) 2016-06-29 2016-06-29 Nuevas formas solidas de desvenlafaxina.

Publications (2)

Publication Number Publication Date
MX2016008646A MX2016008646A (es) 2017-12-28
MX367362B true MX367362B (es) 2019-08-16

Family

ID=60718150

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016008646A MX367362B (es) 2016-06-29 2016-06-29 Nuevas formas solidas de desvenlafaxina.

Country Status (7)

Country Link
US (1) US10207982B2 (es)
CA (1) CA2972156C (es)
CO (1) CO2017006492A1 (es)
ES (1) ES2648369B2 (es)
MX (1) MX367362B (es)
PE (1) PE20180025A1 (es)
SV (1) SV2017005474A (es)

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4535186A (en) 1983-04-19 1985-08-13 American Home Products Corporation 2-Phenyl-2-(1-hydroxycycloalkyl or 1-hydroxycycloalk-2-enyl)ethylamine derivatives
US6197828B1 (en) 1998-12-01 2001-03-06 Sepracor, Inc. Derivatives of (+)-venlafaxine and methods of preparing and using the same
NZ514612A (en) 1999-04-06 2004-01-30 Sepracor Inc Derivatives of venlafaxine and methods of preparing and using the same
BR0207157A (pt) 2001-02-12 2004-02-17 Wyeth Corp Sal de succinato de o-desmetil-venlafaxina
US20110046231A1 (en) 2007-10-22 2011-02-24 Actavis Group Ptc Ehf Solid forms of (±)-o-desmethylvenlafaxine salts
EP2085377A1 (en) 2008-01-29 2009-08-05 LEK Pharmaceuticals D.D. Novel salts of O-desmethyl-venlafaxine
EP2252573A2 (en) * 2008-02-14 2010-11-24 Egis Gyógyszergyár Nyilvánosan Müködö New polymorph and amorphous forms of desvenlafaxine fumarate
IN2008CH00818A (es) * 2008-04-01 2009-10-09 Actavis Group Ptc Ehf
EP2119695A1 (en) 2008-05-16 2009-11-18 Krka Preparation of O-desmethylvenlafaxine salts
US20110112200A1 (en) * 2008-06-16 2011-05-12 Valerie Niddam-Hildesheim Solid states of o-desmethylvenlafaxine salts
CZ2008756A3 (cs) 2008-11-27 2010-03-24 Zentiva, A. S. Zpusob prípravy desvenlafaxinu a jeho solí
CZ2009454A3 (cs) 2009-07-15 2010-11-10 Zentiva, K. S. Zpusob prípravy desvenlafaxinu a jeho solí
EP2340818A1 (en) 2009-12-23 2011-07-06 Laboratorios Del. Dr. Esteve, S.A. Co-crystals of venlafaxine and celecoxib
US8481596B2 (en) * 2011-06-08 2013-07-09 Lupin Limited Polymomorph of desvenlafaxine benzoate

Also Published As

Publication number Publication date
ES2648369A1 (es) 2018-01-02
SV2017005474A (es) 2017-10-12
PE20180025A1 (es) 2018-01-09
CA2972156A1 (en) 2017-12-29
US20180002273A1 (en) 2018-01-04
CO2017006492A1 (es) 2018-01-05
CA2972156C (en) 2024-06-25
ES2648369B2 (es) 2018-06-08
MX2016008646A (es) 2017-12-28
US10207982B2 (en) 2019-02-19

Similar Documents

Publication Publication Date Title
CL2019001066A1 (es) Sal de (s)-csa de s-ketamina, sal de (r)-csa de s-ketamina y procesos para la preparación de s-ketamina (divisional solicitud 201702854)
NZ730724A (en) Novel methyl-piperidine compounds useful for inhibiting microsomal prostaglandin e2 synthase-1
PH12020550703A1 (en) Sulfonamide compounds and use thereof
BR112017009497A2 (pt) polinucleotídeos de aadc para o tratamento da doença de parkinson
MX370450B (es) Co-cristales de moduladores de regulador de conductancia de transmembrana en fibrosis quistica.
CL2016002169A1 (es) Inhibidores de diacilglicerol aciltransferasa 2 para uso en el tratamiento de trastornos metabólicos y relacionados.
CO7310528A2 (es) Composición farmacéutica recubierta que contiene regorafenib
MX2017008136A (es) Sal de l-tartrato de pridopidina.
WO2015110897A3 (en) Novel process for the preparation of dolutegravir and pharmaceutically acceptable salts thereof
PH12017500833A1 (en) Synthesis of copanlisib and its dihydrochloride salt
MX370253B (es) Composiciones de compuestos de jasmonato y métodos de uso de las mismas.
JP2017061576A5 (es)
JO3487B1 (ar) تخليق كوبانليسيب وملح الدايهيدروكلوريد الخاص به
PH12016501483B1 (en) P-substituted asymmetric ureas and medical uses thereof
EA201791645A1 (ru) Новые соли и полиморфы scy-078
AR100095A1 (es) Formas sólidas del ácido {[(2r,3s,4r,5s)-4-(4-cloro-2-fluoro-fenil)-3-(3-cloro-2-fluoro-fenil)-4-ciano-5-(2,2-dimetil-propil)-pirrolidin-2-carbonil]-amino}-3-metoxi-benzoico
IN2014MU00626A (es)
MX2016008646A (es) Nuevas formas solidas de desvenlafaxina.
MX2017004770A (es) Formas solidas del clorhidrato de nilotinib.
EA201791398A1 (ru) Производные фумагиллола
IN2014MU00072A (es)
PH12019502792A1 (en) Tetrahydropyridopyrazine modulators of gpr6
MX2015014702A (es) Un compuesto para usarse en el tratamiento del transtorno de ansiedad comorbida y trastorno de depresion.
BR112018073384A2 (pt) polinucleotídeos moduladores
SG10201900892SA (en) Composition containing apomorphine and a divalent metal cation

Legal Events

Date Code Title Description
GD Licence granted
FG Grant or registration